News & Updates

Show Multimedia Only
Can RA patients taper MTX from targeted therapy?

Can RA patients taper MTX from targeted therapy?

18 Jan 2023

A recent study has found that tapering methotrexate (MTX) from targeted therapy in patients with controlled rheumatoid arthritis (RA) is feasible, but this may result in a 10-percent decrease in the ability to sustain remission for up to 18 months.

18 Jan 2023
Artificial pancreas yields good results in type 2 diabetes patients

Artificial pancreas yields good results in type 2 diabetes patients

17 Jan 2023 byJairia Dela Cruz

A fully closed-loop insulin delivery system, also known as artificial pancreas, helps improve the management of type 2 diabetes in adults, increasing the time spent in target glucose range by 8 hours per day without promoting hypoglycaemic events as compared with standard insulin therapy, as reported in a study.

17 Jan 2023